Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of HRS-7535 in adults with overweight or obesity (HARBOR-1)
CTR20251119Phase 3Completed
- Sponsor
- Shandong Sende
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HRS-7535 in obesity, Overweight, sponsored by Shandong Sende. Started Apr 2025; status: completed.
02
Drugs
HRS-7535
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20251119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251119.